Upadacitinib: First Approval
This article summarizes the milestones in the development of upadacitinib leading to this first approval for the treatment of rheumatoid arthritis.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Arthritis | Drugs & Pharmacology | Marketing | Methotrexate | Rheumatoid Arthritis | Rheumatology